Cogstate Ltd ( (AU:CGS) ) just unveiled an update.
Cogstate Ltd has announced an update regarding its ongoing on-market buy-back program. As of March 27, 2025, the company has repurchased a total of 2,926,978 ordinary fully paid securities, with 34,262 bought back on the previous day. This buy-back initiative is part of Cogstate’s strategy to optimize its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, focusing on cognitive science and technology. The company provides cognitive assessment services and products, primarily targeting clinical trials, academic research, and healthcare markets.
YTD Price Performance: 30.15%
Average Trading Volume: 9,611
Technical Sentiment Signal: Sell
Current Market Cap: $152.6M
Find detailed analytics on CGS stock on TipRanks’ Stock Analysis page.